Skip to main content

PETMED EXPRESS INC

corporate_fare Company Profile

PETMED EXPRESS INC

PETS·NASDAQ·Trade & Services·CIK 0001040130

PetMed Express Inc. operates as a direct-to-consumer pet health and wellness retailer, doing business as PetMeds and as the parent company of PetCareRx. Established in 1996, the company markets and sells products directly to consumers via its websites (Petmeds.com and PetCareRx.com), customer contact centers, and mobile applications (iOS and Android). PetMed Express Inc. provides access to top branded pharmaceuticals, generic medications, compounded prescription medications, and over-the-counter (OTC) health and wellness products. The company also offers prescription and non-prescription food, pharmacy fulfillment services, and personalized AutoShip capabilities. Its digital platform delivers pet healthcare solutions for various chronic conditions, including allergies, arthritis, anxiety, kidney issues, and hyperthyroidism, for cats, dogs, and horses. Additionally, the company provides a range of non-prescription health and wellness products, Rx food, non-Rx food, and treats. PetMeds and PetCareRx process pet orders received through their websites and mobile applications and coordinate with the customer's licensed veterinarian for prescription approval. Through its content website, pethealthmd.com, consumers can access educational articles on pet health. The company has fulfilled orders for almost twenty-million pet parents across all 50 states since its founding 30 years ago.

PETMED EXPRESS INC (NASDAQ:PETS) is a publicly traded company in the Trade & Services sector. Wiseek monitors PETS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • PetMed Express Sales Plunge 20.5% YoY, Customer Adds Fall Sharply
  • PetMed Express Reports Massive Full-Year Loss, Going Concern Doubt, and Unremediated Control Weaknesses
  • PetMed Express Q4 Revenue Plunges 16% on Prescription Sales Decline; Rejects Acquisition Bids
  • PetMed Express Reports Significant Full-Year Loss, Rejects Premium Buyout Offers
  • PetMed Express Reports Q4 Loss of $0.19/Share, Significantly Better Than Expected

Financial Snapshot

Fiscal year ended March 31, 2026
Revenue
$179.02M
Net Income
-$57.29M
Diluted EPS
-$2.74
Op. Cash Flow
-$28.39M
Free Cash Flow
-$33.01M
Gross Profit
$50.22M
Operating Income
-$58.67M
Cash & Equivalents
$21.41M
Debt / Equity
0.00×
Net Margin
-32.0%
Shares Outstanding
21.39M sh
Source: 10-K · filed 2026-06-02 · accession 0001040130-26-000019
Browse all tickers starting with P →
$1.85
52-week range · as of 2026-06-02 $1.57 – $4.32
Market cap
$39.53M
Volume
30.2K (0.2× avg)
3-mo avg 158.1K
Live data · 2026-06-14 03:03 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed PETS - Latest Insights

PETS
Jun 03, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $2.02
Real-time Price: $1.85 info
Change: -$0.1671 (-8%) info
Market Cap: $39.527M info
PETS
Jun 02, 2026, 4:55 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.95
Real-time Price: $1.85 info
Change: -$0.1016 (-5%) info
Market Cap: $39.527M info
PETS
Jun 02, 2026, 4:17 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.13
Real-time Price: $1.85 info
Change: -$0.2791 (-13%) info
Market Cap: $39.527M info
PETS
Jun 02, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $2.12
Real-time Price: $1.85 info
Change: -$0.270 (-13%) info
Market Cap: $39.527M info
PETS
Jun 02, 2026, 4:06 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $2.20
Real-time Price: $1.85 info
Change: -$0.3496 (-16%) info
Market Cap: $39.527M info
PETS
May 29, 2026, 4:02 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.17
Real-time Price: $1.85 info
Change: -$0.320 (-15%) info
Market Cap: $39.527M info
PETS
Apr 22, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.34
Real-time Price: $1.85 info
Change: -$0.490 (-21%) info
Market Cap: $39.527M info
PETS
Feb 11, 2026, 9:45 PM EST
Filing Type: SCHEDULE 13D
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $1.85 info
Change: -$1.13 (-38%) info
Market Cap: $39.527M info
PETS
Feb 05, 2026, 4:10 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.98
Real-time Price: $1.85 info
Change: -$1.13 (-38%) info
Market Cap: $39.527M info